(RTTNews) - Specialty pharmaceutical company Talphera, Inc. (TLPH), Monday announced its agreement with the FDA to reduce the size of the NEPHRO CRRT study to 70 patients from the 166 previously ...
Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ...
PANAMA CITY, Fla. (WJHG/WECP) - Lives are on the line every day in the ICU, and Ascension Sacred Heart Bay now has a new tool to help kidney patients recover. The hospital has added Continuous Renal ...
SAN MATEO, Calif., Aug. 25, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
A UCLA-led team has developed a machine-learning model that can predict with a high degree of accuracy the short-term survival of dialysis patients on Continuous Renal Replacement Therapy (CRRT). CRRT ...
Please provide your email address to receive an email when new articles are posted on . Mortality at 28 days was lower in patients who received continuous renal replacement therapy within 12 hours of ...
Dartmouth Health member hospital Cheshire Medical Center introduced continuous renal replacement therapy (CRRT), a form of 24-hour dialysis, to its intensive care unit in the last year. The new ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/calcimedica-announces-upcoming-plenary-presentation-at-the-30th-international ...
Partnerships with civilian trauma centers and health systems provide an underused way for military medical personnel to obtain clinical experience relevant to both combat medicine and general hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results